Skip to main content
. 2022 Sep 3;14(17):4321. doi: 10.3390/cancers14174321

Table 4.

Summary of the study population.

Variable/Characteristic Sub-Set of Variable Proportion/Mean/Median
Sex Male (661/861) = 76.8%
Female (200/861) = 23.2%
Age (Continuous) Mean = 63.30 (CI: 62.52, 64.08)
Median = 63.00
Age  50 50 (121/861) = 14.1%
>50 (740/861) = 86.9%
Smoking Status Current smoker (479/861) = 55.6%
Ex-smoker (110/861) = 12.8%
Never smoked (156/861) = 18.1%
Unknown (116/861) = 13.5%
Sub-site Oropharynx (209/861) = 24.3%
Oral Cavity (331/861) = 38.4%
Larynx (321/861) = 37.3%
Grade Well-differentiated (88/861) = 10.2%
Moderately differentiated (475/861) = 55.2%
Poorly differentiated (187/861) = 21.7%
Un-differentiated (2/861) = 0.2%
Unknown (109/861) = 12.7%
TNM Stage Stage I (119/861) = 13.8%
Stage II (126/861) = 14.6%
Stage III (133/861) = 15.4%
Stage IV (376/861) = 43.8%
Unknown (107/861) = 12.4%